Marijuana Business Magazine March 2020

Marijuana Business Magazine | March 2020 28 Israeli Cannabis Firm Gets Go-ahead to Export from Uganda Together , a cannabis cultivation and production company in Ashkelon, Israel, received permission from the National Drug Authority of Uganda to export medical cannabis products from Uganda to EU countries Malta and Germany as well as to Israel. Any corporation that requests to import medical cannabis from the company’s farm in Uganda will be required to possess an import/commercial license for medical cannabis products in the destination country. Aphria Receives Key EU Certifications Canadian licensed producer Aphria received its first two essential European quality standard certifications, which will allow the company to export finished dried flower and oil in bulk to European Union countries with established medical marijuana regimes. The company earned a certificate of EU-Good Manufacturing Prac- tice (EU-GMP) compliance for a facility located on its Aphria One campus in Leamington, Ontario. Aphria’s subsidiary in Brampton, Ontario, Ara Avanti Rx Analytics , received EU-GMP certification from the Malta Medicines Authority for manufacturing and packaging. The Brampton company is intended to be used as the Canadian staging site for internationally bound, GMP-certified medical marijuana products, Aphria said in a regulatory filing. Vancouver Investment Firm Partners With Israeli Cannabis Company Nabis Holdings , a cannabis-focused investment company based in Vancouver, British Columbia, entered into a binding memorandum of understand- ing with Panaxia Pharmaceutical Industries , an Israeli cannabis cultivator and product manufac- turer. Under the terms of the MOU, Panaxia will provide proprietary pharmaceutical-grade canna- bis-based products. Nabis will provide the raw materials to manufacture the products and also will be responsible for sales, marketing and distribution through established dispensary and wholesale channels, which serve more than 50% of Arizona dispensaries. Panaxia will be responsible for production, clinical affairs and product quality. All products of the joint venture will be sold under the Panaxia brand, of which Nabis owns 50% in Arizona. Under the MOU, there is an opportunity for Nabis and Panaxia to expand their joint venture into additional states. Have a company announcement you want us to consider? Send a news release or general information to omars@mjbizdaily.com . (Note: We’re looking for news about expansions, financing, deals, partnerships and similar developments, not product-related announcements.) INTERNATIONAL DEVELOPMENTS Toronto CBD Company Opens Swiss Store MPX International, a Toronto cannabis company, opened its first Holyweed CBD retail store in a tourism district of Geneva, Switzerland. The location carries all Holyweed “Swiss Certified Organic” branded products as well as products from several other premium CBD brands. MPX opened its first European CBD store last November in London and plans to open another store this year in Zurich. Biopharma Company and Pharmacy Chain Partner Avicanna , a biopharmaceutical company in Toronto, announced an agreement with Toronto-based Shoppers Drug Mart to supply Canada’s largest pharmacy chain with medical cannabis. Avicanna will have one or more Canadian producers manufacture the products, which will then be sold under Avicanna’s brands Rho Phyto medical cannabis and Pura Earth CBD cosmetics. Later, pending regulatory allowance, the products might be shipped to Canada from Avicanna’s Colombian operations, CEO Aras Azadian told Marijuana Business Daily . The medicines are expected to become available in early 2020, according to a news release. Financial terms of the agreement were not disclosed. The company’s products will be available only in the medical market. Avicanna’s announcement also mentioned that sales efforts will be accompanied by “education, training and ongoing support” of the medical community. Quebec License Holder Moves HQ to Ottawa Hexo , which bills itself as Quebec’s largest federally licensed cannabis producer, moved its corporate head office from Gatineau, Quebec, to Ottawa, Ontario. Hexo Vice President of Communications Isabelle Robillard said the company tried to avoid the administrative change, but “this choice was imposed on us, as we are unable to secure Directors and Officers Liability Insurance if we are based in Quebec.” She said the move has no impact on Hexo’s Quebec operations, nor any of its employees there. CompanyNews | U.S., Canada & International